Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 9/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 2/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20168559 | 1.00 | MGAM (0.42) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL25341709 | 0.94 | NAAA (0.34) | MGAMGAASIMGAM2ARG1 | |
| SCHEMBL25341713 | 0.87 | ARG1 (0.34) | GAAARG1NAAA | |
| SCHEMBL12332968 | 0.86 | MGAM (0.44) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL17629469 | 0.82 | NAAA (0.32) | ARG1NAAA | |
| SCHEMBL30013264 | 0.82 | NAAA (0.32) | ARG1NAAA | |
| SCHEMBL6870122 | 0.82 | NAAA (0.32) | ARG1NAAA | |
| SCHEMBL756557 | 0.81 | ARG1 (0.34) | GAAALDH1A1ARG1NAAA | |
| SCHEMBL23824765 | 0.81 | ALDH1A1 (0.36) | MGAMGAASIMGAM2EPHX2 | |
| SCHEMBL6869259 | 0.80 | MEN1 (0.33) | EPHX2ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4139041-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-03-01 | — | — | EP | claimed |
| EP-4120991-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | Givaudan SA (CH) | 2023-01-25 | — | — | EP | claimed |
| WO-2021213930-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2021-10-28 | — | — | WO | claimed |
| WO-2021185736-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | GIVAUDAN SA (CH) | 2021-09-23 | — | — | WO | claimed |
| EP-4433483-B1 | FRAGRANCE SUBSTANCES AND FORMULATION CONTAINING THEM | INT FLAVORS & FRAGRANCES INC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4659819-A2 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | International Flavors & Fragrances Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| US-12428609-B2 | Organoleptic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4416137-B1 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | INT FLAVORS & FRAGRANCES INC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250034073-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-01-30 | — | — | US | disclosed |
| US-20240391891-A1 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2024-11-28 | — | — | US | disclosed |
| EP-4433483-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | International Flavors & Fragrances Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-4416137-A1 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | International Flavors & Fragrances Inc. (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20130109761-A1 | OCTAHYDRO-1H-4,7-METHANO-INDENE-5-ALDEHYDES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2013-05-02 | — | — | US | disclosed |
| US-8309511-B1 | 3(or 2),4,5-trimethyl-octahydro-4,7-methano-inden-5-ol and its use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2012-11-13 | — | — | US | disclosed |
| US-20120277325-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-11-01 | — | — | US | disclosed |
| US-20120207698-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-08-16 | — | — | US | disclosed |
| US-20120183490-A1 | NOVEL 1,3-OXATHIANE COMPOUNDS AND THEIR USE IN FLAVOR AND FRAGRANCE COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-07-19 | — | — | US | disclosed |
| US-8114823-B2 | Isomers of bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, ethyl ester and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2012-02-14 | — | — | US | disclosed |
| US-20120010301-A1 | ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-01-12 | — | — | US | disclosed |
| US-20120004326-A1 | ISOMERS OF BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID, ETHYL ESTER AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120277325-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS | DPYD, HINT1, MTR | MGAM 4565/4885GAA 4810/4885SI 4521/4885 |
| US-12428609-B2 | Organoleptic compounds | TRPA1, TRPV1, TRPV5 | MGAM 4082/4885GAA 3600/4885SI 3500/4885 |
| US-20130109761-A1 | OCTAHYDRO-1H-4,7-METHANO-INDENE-5-ALDEHYDES AND THEIR USE IN PERFUME COMPOSITIONS | MSMO1, ADH5, TRPA1 | MGAM 3680/4885GAA 4773/4885SI 2603/4885 |
| US-20240391891-A1 | A NOVEL FURAN COMPOUND AND ITS USE IN FRAGRANCE FORMULATIONS | TRPA1, TRPV1, TRPV5 | MGAM 4365/4885GAA 3968/4885SI 3888/4885 |
| US-20120004326-A1 | ISOMERS OF BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID, ETHYL ESTER AND THEIR USE IN PERFUME COMPOSITIONS | ELOVL5, CYP8B1, CYP1B1 | MGAM 3465/4885GAA 4199/4885SI 2419/4885 |
| US-20120207698-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS | DPYD, TYMP, IMPDH1 | MGAM 4792/4885GAA 3944/4885SI 3818/4885 |
| US-20120183490-A1 | NOVEL 1,3-OXATHIANE COMPOUNDS AND THEIR USE IN FLAVOR AND FRAGRANCE COMPOSITIONS | TAS1R1, TAS2R1, TAS1R3 | MGAM 3303/4885GAA 4582/4885SI 3601/4885 |
| US-20250034073-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | TRPA1, TRPV1, TRPV5 | MGAM 4254/4885GAA 3941/4885SI 4083/4885 |
| US-20120010301-A1 | ORGANOLEPTIC COMPOUNDS | TRPA1, OR51E2, OR10J3 | MGAM 4456/4885GAA 4527/4885SI 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.